tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoff Meacham, 207 are a HOLD (36.83%), 322 are a BUY (57.3%), 33 are a SELL (5.87%).
Analyst Geoff Meacham, currently employed at CITI, carries an average stock price target met ratio of 61.65% that have a potential upside of 27.78% achieved within 268 days.
Geoff Meacham’s has documented 1,111 price targets and ratings displayed on 76 stocks. The coverage is on Healthcare, Technology, Industrials, Basic Materials sectors.
Most recent stock forecast was given on MRNA, Moderna at 29-Sep-2026.
Analyst best performing recommendations are on TYRA (TYRA BIOSCIENCES).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) at 2/27/2023. The price target of $15 was fulfilled within 7 days with a profit of $3.42 (29.53%) receiving and performance score of 42.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 4 months 27 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 4 months 29 days ago
(03-May-2021)
17/29 (58.62%)
$2.73 (1.60%)
650
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 5 months 6 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 7 months 28 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 17-Jul-2017
$166
$-16.5 (-9.04%)
$175
5 years 7 months 28 days ago
(04-Feb-2021)
32/33 (96.97%)
$10.41 (6.69%)
867
Which stock is Geoff Meacham most bullish on?
Which stock is Geoff Meacham most reserved on?
What Year was the first public recommendation made by Geoff Meacham?
